CHEK1 and neoplasm: Overall, the consensus of pre-clinical evidence suggests that inhibiting cell cycle checkpoint activation post-irradiation via Chk1 inhibition results in an increase in unrepairable DNA damage, pre-mature mitotic entry, chromosomal aberrations and mitotic catastrophe, subsequently increasing tumour cell death.